-
Specialties
Patient Rating
4.9 /5( out of 123 reviews )The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety.
Patients are de-identified for confidentiality and patient privacy.October 31, 2024SUGAR HOUSE HEALTH CENTERDr.Dood is fantastic! He made me feel comfortable, and it was very easy to develop a good rapport with him. He explained everything in detail, in a way that was easily understandable. I felt like I could trust him to provide me with the best care possible.
October 29, 2024SUGAR HOUSE HEALTH CENTERDr. Dood is a thorough, respectful, knowledgeable, respectful provider.
October 10, 2024SUGAR HOUSE HEALTH CENTERDr Dood is skilled, compassionate and thorough!
October 10, 2024SUGAR HOUSE HEALTH CENTERI am so impressed with the care I have received by Dr Dood. He has been helpful and attentive, and gone to great lengths to make sure I understood each step of treatment. And he loves dragons!
September 05, 2024SUGAR HOUSE HEALTH CENTERVery kind and thorough. Explained everything so I would understand.
July 31, 2024HUNTSMAN CANCER CENTERDr. Dood is the best Doctor I have ever had, I recommend if you need treatment for all girl cancer that you see him.
July 18, 2024SUGAR HOUSE HEALTH CENTERDr. Dood is very nice and thorough. He explains everything good or bad and what to expect with all.
July 12, 2024SUGAR HOUSE HEALTH CENTERI find Dr. Dood to be very kind and considerate.
July 12, 2024SUGAR HOUSE HEALTH CENTERDr. Dood is very personable and caring. He provides excellent care. His explanation of my treatment plan and care is thorough and well thought out. His knowledge and attention to treatment planning as a physician is very reassuring. I have felt very confident in my treatment provided under his care. Thank you Dr. Dood for your excellent care both in my surgery and after care!!
-
Board Certification and Academic Information
Academic Departments Obstetrics & Gynecology -Primary Academic Divisions Gynecological Oncology
Selected Publications
Journal Article
- Dood RL, Zhao Y, Armbruster SD, Coleman RL, Tworoger S, Sood AK, Baggerly KA (2018). Defining Survivorship Trajectories Across Patients with Solid Tumors: An Evidence-Based Approach. JAMA Oncol, 4(11), 1519-1526. ()
- Dood RL, Fleming ND, Coleman RL, Westin SN, Lara OD, LaFargue CJ, Liu J, Sood AK (2018). When Ovarian Cancer Is Not: Characterizing Nonovarian Cancer Pathology in a Laparoscopy-Based Triage System. Int J Gynecol Cancer, 28(8), 1485-1490. ()
- Nagaraja AS, Dood RL, Armaiz-Pena G, Kang Y, Wu SY, Allen JK, Jennings NB, Mangala LS, Pradeep S, Lyons Y, Haemmerle M, Gharpure KM, Sadaoui NC, Rodriguez-Aguayo C, Ivan C, Wang Y, Baggerly K, Ram P, Lopez-Berestein G, Liu J, Mok SC, Cohen L, Lutgendorf SK, Cole SW, Sood AK (2018). Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens. JCI Insight, 3(11). ()
- Huang Y, Hu W, Huang J, Shen F, Sun Y, Ivan C, Pradeep S, Dood R, Haemmerle M, Jiang D, Mangala LS, Noh K, Hansen JM, Dalton HJ, Previs RA, Nagaraja AS, McGuire M, Jennings NB, Broaddus R, Coleman RL, Sood AK (2017). Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer. Mol Cancer Ther, 17(2), 464-473. ()
- Lyons YA, Pradeep S, Wu SY, Haemmerle M, Hansen JM, Wagner MJ, Villar-Prados A, Nagaraja AS, Dood RL, Previs RA, Hu W, Zhao Y, Mak DH, Xiao Z, Melendez BD, Lizee GA, Mercado-Uribe I, Baggerly KA, Hwu P, Liu J, Overwijk WW, Coleman RL, Sood AK (2017). Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy. Oncotarget, 8(57), 96496-96505. ()
- Haemmerle M, Taylor ML, Gutschner T, Pradeep S, Cho MS, Sheng J, Lyons YM, Nagaraja AS, Dood RL, Wen Y, Mangala LS, Hansen JM, Rupaimoole R, Gharpure KM, Rodriguez-Aguayo C, Yim SY, Lee JS, Ivan C, Hu W, Lopez-Berestein G, Wong ST, Karlan BY, Levine DA, Liu J, Afshar-Kharghan V, Sood AK (2017). Platelets reduce anoikis and promote metastasis by activating YAP1 signaling. Nat Commun, 8(1), 310. ()
- Nagaraja AS, Dood RL, Armaiz-Pena G, Kang Y, Wu SY, Allen JK, Jennings NB, Mangala LS, Pradeep S, Lyons Y, Haemmerle M, Gharpure KM, Sadaoui NC, Rodriguez-Aguayo C, Ivan C, Wang Y, Baggerly K, Ram P, Lopez-Berestein G, Liu J, Mok SC, Cohen L, Lutgendorf SK, Cole SW, Sood AK (2017). Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens. JCI Insight, 2(16). ()
- Sans M, Gharpure K, Tibshirani R, Zhang J, Liang L, Liu J, Young JH, Dood RL, Sood AK, Eberlin LS (2017). Metabolic Markers and Statistical Prediction of Serous Ovarian Cancer Aggressiveness by Ambient Ionization Mass Spectrometry Imaging. Cancer Res, 77(11), 2903-2913. ()
- Dood RL, Gracia CR, Sammel MD, Haynes K, Senapati S, Strom BL (2014). Endometrial cancer after endometrial ablation vs medical management of abnormal uterine bleeding. J Minim Invasive Gynecol, 21(5), 744-52. ()
Letter
- Dood RL (2014). Reply: To PMID 24590007. [Letter to the editor]. J Minim Invasive Gynecol, 22(3), 510. ()
( out of 123 reviews )